A Machine Learning Method to Identify the Risk Factors for Liver Fibrosis Progression in Nonalcoholic Steatohepatitis

被引:7
|
作者
Suarez, Miguel [1 ,2 ]
Martinez, Raquel [1 ]
Torres, Ana Maria [2 ]
Torres, Beatriz [3 ]
Mateo, Jorge [2 ]
机构
[1] Virgen Luz Hosp, Gastroenterol Dept, Ave Hermandad Donantes Sangre 1, Cuenca 16002, Spain
[2] Univ Castilla La Mancha, Inst Technol, Med Anal Expert Grp, Cuenca, Spain
[3] Obispo Polanco Hosp, Teruel, Spain
关键词
Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Liver fibrosis; Machine learning; DISEASE; CLASSIFICATION; PREVALENCE;
D O I
10.1007/s10620-023-08031-y
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AimNonalcoholic fatty liver disease (NAFLD) is a silent epidemy that has become the most common chronic liver disease worldwide. Nonalcoholic steatohepatitis (NASH) is an advanced stage of NAFLD, which is linked to a high risk of cirrhosis and hepatocellular carcinoma. The aim of this study is to develop a predictive model to identify the main risk factors associated with the progression of hepatic fibrosis in patients with NASH.MethodsA database from a multicenter retrospective cross-sectional study was analyzed. A total of 215 patients with NASH biopsy-proven diagnosed were collected. NAFLD Activity Score and Kleiner scoring system were used to diagnose and staging these patients. Noninvasive tests (NITs) scores were added to identify which one were more reliable for follow-up and to avoid biopsy. For analysis, different Machine Learning methods were implemented, being the eXtreme Gradient Booster (XGB) system the proposed algorithm to develop the predictive model.ResultsThe most important variable in this predictive model was High-density lipoprotein (HDL) cholesterol, followed by systemic arterial hypertension and triglycerides (TG). NAFLD Fibrosis Score (NFS) was the most reliable NIT. As for the proposed method, XGB obtained higher results than the second method, K-Nearest Neighbors, in terms of accuracy (95.05 vs. 90.42) and Area Under the Curve (0.95 vs. 0.91).ConclusionsHDL cholesterol, systemic arterial hypertension, and TG were the most important risk factors for liver fibrosis progression in NASH patients. NFS is recommended for monitoring and decision making.
引用
收藏
页码:3801 / 3809
页数:9
相关论文
共 50 条
  • [41] An explainable machine learning model for prediction of high-risk nonalcoholic steatohepatitis
    Njei, Basile
    Osta, Eri
    Njei, Nelvis
    Al-Ajlouni, Yazan A.
    Lim, Joseph K.
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [42] MACHINE LEARNING FIBROSIS MODELS BASED ON LIVER HISTOLOGY IMAGES ACCURATELY CHARACTERIZE THE HETEROGENEITY OF CIRRHOSIS DUE TO NONALCOHOLIC STEATOHEPATITIS (NASH)
    Younossi, Zobair M.
    Pokkalla, Harsha
    Pethia, Kishalve
    Glass, Benjamin
    Kerner, Jennifer Kaplan
    Gindin, Yevgeniy
    Han, Ling
    Huss, Ryan
    Chung, Chuhan
    Djedjos, Stephen
    Subramanian, Mani
    Myers, Robert P.
    Khosla, Aditya
    Resnick, Murray
    Harrison, Stephen A.
    Anstee, Quentin M.
    Wong, Vincent Wai-Sun
    Wapinski, Ilan
    Beck, Andrew
    Goodman, Zachary D.
    HEPATOLOGY, 2019, 70 : 1033A - 1034A
  • [43] Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis
    Younossi, Zobair M.
    Loomba, Rohit
    Anstee, Quentin M.
    Rinella, Mary E.
    Bugianesi, Elisabetta
    Marchesini, Giulio
    Neuschwander-Tetri, Brent A.
    Serfaty, Lawrence
    Negro, Francesco
    Caldwell, Stephen H.
    Ratziu, Vlad
    Corey, Kathleen E.
    Friedman, Scott L.
    Abdelmalek, Manal F.
    Harrison, Stephen A.
    Sanyal, Arun J.
    Lavine, Joel E.
    Mathurin, Philippe
    Charlton, Michael R.
    Goodman, Zachary D.
    Chalasani, Naga P.
    Kowdley, Kris V.
    George, Jacob
    Lindor, Keith
    HEPATOLOGY, 2018, 68 (01) : 349 - 360
  • [44] The Role of Senescence in the Development of Nonalcoholic Fatty Liver Disease and Progression to Nonalcoholic Steatohepatitis
    Papatheodoridi, Alkistis-Maria
    Chrysavgis, Lampros
    Koutsilieris, Michael
    Chatzigeorgiou, Antonios
    HEPATOLOGY, 2020, 71 (01) : 363 - 374
  • [45] Application of Interpretable Machine Learning Models Based on Ultrasonic Radiomics for Predicting the Risk of Fibrosis Progression in Diabetic Patients with Nonalcoholic Fatty Liver Disease
    Meng, Fei
    Wu, Qin
    Zhang, Wei
    Hou, Shirong
    DIABETES METABOLIC SYNDROME AND OBESITY, 2023, 16 : 3901 - 3913
  • [46] MACHINE LEARNING MODELS ACCURATELY INTERPRET LIVER HISTOLOGY IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH)
    Pokkalla, Harsha
    Pethia, Kishalve
    Glass, Benjamin
    Kerner, Jennifer K.
    Gindin, Yevgeniy
    Han, Ling
    Huss, Ryan
    Chung, Chuhan
    Djedjos, Stephen
    Subramanian, Mani
    Myers, Robert P.
    Resnick, Murray
    Harrison, Stephen A.
    Goodman, Zachary D.
    Khosla, Aditya
    Beck, Andrew
    Wapinski, Ilan
    Younossi, Zobair M.
    HEPATOLOGY, 2019, 70 : 121A - 122A
  • [47] Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis
    Zhu, Changyu
    Kim, KyeongJin
    Wang, Xiaobo
    Bartolome, Alberto
    Salomao, Marcela
    Dongiovanni, Paola
    Meroni, Marica
    Graham, Mark J.
    Yates, Katherine P.
    Diehl, Anna Mae
    Schwabe, Robert F.
    Tabas, Ira
    Valenti, Luca
    Lavine, Joel E.
    Pajvani, Utpal B.
    SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (468)
  • [48] Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.
    Angulo, P
    Keach, JC
    Batts, KP
    Lindor, KD
    HEPATOLOGY, 1999, 30 (04) : 406A - 406A
  • [49] An integrated view of liver injury and disease progression in nonalcoholic steatohepatitis
    Sanyal, Arun J.
    HEPATOLOGY INTERNATIONAL, 2013, 7 : S800 - S805
  • [50] An integrated view of liver injury and disease progression in nonalcoholic steatohepatitis
    Arun J. Sanyal
    Hepatology International, 2013, 7 : 800 - 805